advertisement

---

Stahnke T 14

Showing records 1 to 14 | Display all abstracts from Stahnke T

107948 Development of a Novel Valve-Controlled Drug-Elutable Microstent for Microinvasive Glaucoma Surgery: In Vitro and Preclinical In Vivo Studies
Siewert S
Translational vision science & technology 2023; 12: 4

---

107917 The Antibiotic Kitasamycin-A Potential Agent for Specific Fibrosis Preventing Therapy after Fistulating Glaucoma Surgery?
Sterenczak KA
Pharmaceutics 2023; 15:

---

107611 Quantitative systems pharmacology of the eye: Tools and data for ocular QSP
Kuepfer L; Fuellen G
CPT: pharmacometrics & systems pharmacology 2023; 12: 288-299

---

107917 The Antibiotic Kitasamycin-A Potential Agent for Specific Fibrosis Preventing Therapy after Fistulating Glaucoma Surgery?
Fuellen G
Pharmaceutics 2023; 15:

---

107948 Development of a Novel Valve-Controlled Drug-Elutable Microstent for Microinvasive Glaucoma Surgery: In Vitro and Preclinical In Vivo Studies
Kischkel S; Brietzke A
Translational vision science & technology 2023; 12: 4

---

107611 Quantitative systems pharmacology of the eye: Tools and data for ocular QSP
Stahnke T
CPT: pharmacometrics & systems pharmacology 2023; 12: 288-299

---

107917 The Antibiotic Kitasamycin-A Potential Agent for Specific Fibrosis Preventing Therapy after Fistulating Glaucoma Surgery?
Jünemann A
Pharmaceutics 2023; 15:

---

107948 Development of a Novel Valve-Controlled Drug-Elutable Microstent for Microinvasive Glaucoma Surgery: In Vitro and Preclinical In Vivo Studies
Kinzel L
Translational vision science & technology 2023; 12: 4

---

107917 The Antibiotic Kitasamycin-A Potential Agent for Specific Fibrosis Preventing Therapy after Fistulating Glaucoma Surgery?
Guthoff RF
Pharmaceutics 2023; 15:

---

107948 Development of a Novel Valve-Controlled Drug-Elutable Microstent for Microinvasive Glaucoma Surgery: In Vitro and Preclinical In Vivo Studies
Lindner T
Translational vision science & technology 2023; 12: 4

---

107917 The Antibiotic Kitasamycin-A Potential Agent for Specific Fibrosis Preventing Therapy after Fistulating Glaucoma Surgery?
Stachs O
Pharmaceutics 2023; 15:

---

107948 Development of a Novel Valve-Controlled Drug-Elutable Microstent for Microinvasive Glaucoma Surgery: In Vitro and Preclinical In Vivo Studies
Hinze U
Translational vision science & technology 2023; 12: 4

---

107917 The Antibiotic Kitasamycin-A Potential Agent for Specific Fibrosis Preventing Therapy after Fistulating Glaucoma Surgery?
Stahnke T
Pharmaceutics 2023; 15:

---

107948 Development of a Novel Valve-Controlled Drug-Elutable Microstent for Microinvasive Glaucoma Surgery: In Vitro and Preclinical In Vivo Studies
Chichkov B; Schmidt W; Stiehm M; Grabow N; Guthoff RF; Schmitz KP; Stahnke T
Translational vision science & technology 2023; 12: 4

---